New Meds and Tech from PES Drugs and Therapeutics committee

Saxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page, MD and Shilpa Mehta, MD Up to date as of December 10, 2020 On December 4,…

Read More

New Meds and Tech from PES Drugs and Therapeutics committee

Hydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks and Kyriakie Sarafoglou Up to date as of: November 4, 2020 On September 29, 2020, the…

Read More

New Meds and Tech from PES Drugs and Therapeutics Committee (Liraglutide)

Prepared by: Vandana Raman, Shilpa Mehta, and Amit Lahoti. Last Updated on: 8/11/20 Liraglutide is a long-acting analog of human glucagon-like peptide (GLP)-1. It was approved…

Read More

New Meds and Tech: Burosumab Twza (Crysvita – Ultragenyx Pharmaceuticals)

Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast…

Read More

New Meds and Tech: Semglee

Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc.…

Read More

New Meds and Tech: Freestyle Libre 2

Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system.…

Read More

New Meds and Tech: Riomet ER™

Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in…

Read More

New Meds and Tech: Tandem® Diabetes Care Control-IQ Technology

In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…

Read More

New Meds and Tech: New Cortisol Assays, New Threshold for Adrenal Insufficiency

 

Read More

New Meds and Tech: Newer Insulin Preparation – Faster Insulin Aspart (Fiasp)

Fiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…

Read More